CAI – caris life sciences, inc. (US:NASDAQ)

News

Caris Life Sciences Introduces Powerful New Caris AI Insights to Identify Early Platinum Resistance in Ovarian Cancer [Yahoo! Finance]
Caris Life Sciences Introduces Powerful New Caris AI Insights to Identify Early Platinum Resistance in Ovarian Cancer
Caris Life Sciences (CAI) had its price target lowered by Canaccord Genuity Group Inc. from $30.00 to $22.00. They now have a "hold" rating on the stock.
Caris Life Sciences to Showcase Five Studies at the 2026 USCAP Annual Meeting [Yahoo! Finance]
Caris Life Sciences to Showcase Five Studies at the 2026 USCAP Annual Meeting
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com